The potentially beneficial central nervous system activity profile of ivacaftor and its metabolites

Ivacaftor–lumacaftor and ivacaftor are two new breakthrough cystic fibrosis transmembrane conductance modulators. The interactions of ivacaftor and its two metabolites hydroxymethylivacaftor (iva-M1) and ivacaftorcarboxylate (iva-M6) with neurotransmitter receptors were investigated in radioligand b...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneider, Elena K., McQuade, Rachel M., Carbone, Vincenzo C., Reyes-Ortega, Felisa, Wilson, John W., Button, Brenda, Saito, Ayame, Poole, Daniel P., Hoyer, Daniel, Li, Jian, Velkov, Tony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850045/
https://www.ncbi.nlm.nih.gov/pubmed/29560360
http://dx.doi.org/10.1183/23120541.00127-2017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850045/
https://www.ncbi.nlm.nih.gov/pubmed/29560360
http://dx.doi.org/10.1183/23120541.00127-2017

Ejemplares similares